The pressing issue of type 2 diabetes recently took on an unexpected spokesman: Paula Deen. Ever since the highly publicized announcement of her illness and related drug endorsement, a hailstorm of negative and positive reactions has made its way to all forms of media. Instead of adding yet another voice to the chorus, I’ve decided to share some breaking information for Ms. Deen and other type-2 diabetics that may improve their health care prospects.

Read more »